尽管年轻患者和HLA匹配,但在基于旅行的SCT中GVHD的高流行率
Naveed Syed1, Imrana Afrooz2, Farooq Ahmed Mir1
1Department of Hematology-Oncology, Sheikh Shakbout Medical City, Abu Dhabi, UAE.
概括
国际干细胞移植 (SCT) 患者返回家园时,即使有有利因素,也会面临高患病率的移植与宿主疾病 (GVHD). 需要进一步的研究来了解导致的因素,并改善这些患者的护理.
科学领域:
- 血液学
- 免疫学
- 移植医学
背景情况:
- 接受干细胞移植 (SCT) 的患者经常出国接受治疗,然后返回缺乏专门设施的国家.
- 国际SCT患者返回进行移植后护理的移植对宿主疾病 (GVHD) 数据有限.
- 这项研究解决了有关该特定患者群体GVHD患病率和风险因素的信息短缺问题.
研究的目的:
- 分析在国外接受干细胞移植 (SCT) 的患者中移植与宿主疾病 (GVHD) 的流行情况.
- 在国际SCT接受者中确定与GVHD相关的关键风险因素.
- 评估特定GVHD表现的发生率,如眼部和肺部GVHD.
主要方法:
- 在2019年1月至2022年12月期间,一项观察性研究分析了91名国际SCT患者的数据.
- 使用电子医疗记录进行数据收集.
- 使用描述性统计,推断测试和森林地块的相对风险计算来评估GVHD的流行率和风险因素.
主要成果:
- 在接受全基性SCT的患者中,GVHD的总流行率为50%.
- 成年患者 (62. 2%) 的GVHD发病率高于儿童患者 (26%).
- 来自不相关的相同捐赠者的接受者显示GVHD的患病率为71%;而来自相关的HLA相同捐赠者的接受者则为50%. 眼部和肺部GVHD显示出意想不到的流行模式.
结论:
- 在国际SCT患者中观察到高GVHD患病率,尽管年轻和相匹配的相关捐赠者等有利因素.
- 眼部GVHD的发病率低于预期,肺部GVHD与已知的危险因素的相关性较弱.
- 建议进行更大规模的多中心研究,以证实这些发现,并阐明该群体GVHD的促成因素.
更多相关视频
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
7.2K
09:00High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
16.0K
相关概念视频
Bone Marrow Sampling and Transplants
495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Tissue Transplantation
519
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
519
Cell-mediated Immune Responses
72.4K
Overview
72.4K
